IOBT - IO Biotech, Inc.
0.985
-0.085 -8.629%
Share volume: 65,157
Last Updated: 05-07-2025
Pharmaceutical Products/Pharmaceutical Preparations:
-0.13%
PREVIOUS CLOSE
CHG
CHG%
$1.07
-0.09
-0.08%
View ratios
Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | |
---|---|---|---|---|
Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | |
Report Date | 05-14-2024 | 08-13-2024 | 11-12-2024 | |
Total revenue | 0.000 | 0.000 | 0.000 | |
Cost of revenue | 0.000 | 0.000 | 0.000 | |
Gross profit | 0.000 | 0.000 | 0.000 | |
nan% | nan% | |||
Operating expenses | 20.197 M | 21.533 M | 26.504 M | |
Selling general and admin | 5.886 M | 5.685 M | 6.326 M | |
Research and development | 14.311 M | 15.848 M | 20.178 M | |
Total expenses | 20.197 M | 21.533 M | 26.504 M | |
6.61% | 23.09% | |||
Operating income | -20.197 M | -21.533 M | -26.504 M | |
Ebit | -20.659 M | -21.623 M | -24.874 M | |
Pretax income | -19.042 M | -20.312 M | -23.806 M | |
6.67% | 17.20% | |||
Income tax | 415.000 K | 374.000 K | 209.000 K | |
Net income basic | 0.000 | 0.000 | 0.000 | |
Net income | -19.457 M | -20.686 M | -24.015 M | |
-6.32% | -16.09% |